Chanelle founder invests €100k in Redesdale Group
Michael Burke has taken a stake in a firm that will seek to acquire or invest in early stage food and wellness businesses
Michael Burke, the founder of Chanelle Pharmaceuticals, has joined veteran financier John Conroy’s Redesdale Group as a shareholder.
Set up by Conroy, the Merrion Capital founder, and formerly called Acton Health & Wellness Fund, Redesdale Group is expected to close an initial funding round in the region of €25 million later this quarter, sources familiar with the venture said.
Burke has invested in the region of €100,000 as part of his involvement in...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Malin shareholders in line for windfall after €119 million cash boost
Dublin-based biotech investment fund said €45 million of the proceeds from the sale will be used to repay a European Investment Bank loan, with the remaining cash to be returned to shareholders later this year
Amryt seeks to have rare condition drug approved for payment
The Dublin company is in discussion with regulators in Britain and France to have metreleptin, a treatment for abnormal distribution of fat in the body, approved for payment reimbursement
Icon to restore staff pay as business recovers from virus
Clinical trials firm reported 10.8% drop in revenues for the three months to the end of June
Comment: Cutting-edge pharma research can bring investment to Ireland
We have the potential to become Europe’s go-to destination for the development of advanced therapy medicinal products